These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

969 related articles for article (PubMed ID: 34499821)

  • 1. SARS-CoV-2 infection shortly after BNT162b2 vaccination results in high anti-spike antibody levels in nursing home residents and staff.
    Urlaub D; Wolfsdorff N; Durak D; Renken F; Watzl C
    Immun Inflamm Dis; 2021 Dec; 9(4):1702-1706. PubMed ID: 34499821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of the BNT162b2 vaccine during a COVID-19 nursing home outbreak.
    McEllistrem MC; Clancy CJ; Buehrle DJ; Lucas A; Pruskowski J; Handler SM; Decker BK
    Am J Infect Control; 2021 Oct; 49(10):1237-1241. PubMed ID: 34363871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents.
    Chong Y; Goto T; Tani N; Yonekawa A; Ikematsu H; Shimono N; Tanaka Y; Akashi K
    Influenza Other Respir Viruses; 2022 Nov; 16(6):1066-1071. PubMed ID: 35962568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreak of SARS-CoV-2 B.1.617.2 (delta) variant in a nursing home 28 weeks after two doses of mRNA anti-COVID-19 vaccines: evidence of a waning immunity.
    Pierobon A; Zotto AD; Antico A; De Antoni ME; Vianello L; Gennari M; Di Caprio A; Russo F; Brambilla G; Saugo M
    Clin Microbiol Infect; 2022 Apr; 28(4):614.e5-614.e7. PubMed ID: 34958917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
    Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA
    BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.
    Cabezas C; Coma E; Mora-Fernandez N; Li X; Martinez-Marcos M; Fina F; Fabregas M; Hermosilla E; Jover A; Contel JC; Lejardi Y; Enfedaque B; Argimon JM; Medina-Peralta M; Prieto-Alhambra D
    BMJ; 2021 Aug; 374():n1868. PubMed ID: 34407952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.
    Meyers E; Deschepper E; Duysburgh E; De Rop L; De Burghgraeve T; Van Ngoc P; Digregorio M; Delogne S; Coen A; De Clercq N; Buret L; Coenen S; Sutter A; Scholtes B; Verbakel JY; Cools P; Heytens S
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achievement of sufficient antibody response after a fourth dose of wild-type SARS-CoV-2 mRNA vaccine in nursing home residents.
    Chong Y; Goto T; Watanabe H; Tani N; Yonekawa A; Ikematsu H; Shimono N; Tanaka Y; Akashi K
    Immun Inflamm Dis; 2023 Aug; 11(8):e962. PubMed ID: 37647452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.
    Canaday DH; Carias L; Oyebanji OA; Keresztesy D; Wilk D; Payne M; Aung H; St Denis K; Lam EC; Rowley CF; Berry SD; Cameron CM; Cameron MJ; Wilson B; Balazs AB; Gravenstein S; King CL
    Clin Infect Dis; 2021 Dec; 73(11):2112-2115. PubMed ID: 33993265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.
    Olariu TR; Ursoniu S; Marincu I; Lupu MA
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946275
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.
    Meyers E; De Rop L; Deschepper E; Duysburgh E; De Burghgraeve T; Van Ngoc P; Digregorio M; Delogne S; Coen A; De Clercq N; Buret L; Coenen S; De Sutter A; Scholtes B; Verbakel JY; Cools P; Heytens S
    Eur J Gen Pract; 2023 Dec; 29(2):2149732. PubMed ID: 36440533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
    Torres I; Bellido-Blasco JB; Gimeno C; Burgos JS; Albert E; Moya-Malo R; Gascó-Laborda JC; Tornero A; Soriano J; Meseguer-Ferrer N; Martínez-Serrano M; Ortíz-Rambla J; Buj H; Hernández N; Peiró S; Salas D; Limón R; Vanaclocha H; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Navarro D;
    J Med Virol; 2022 Aug; 94(8):3776-3782. PubMed ID: 35445415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.
    Torres I; Albert E; Giménez E; Alcaraz MJ; Botija P; Amat P; Remigia MJ; Beltrán MJ; Rodado C; Huntley D; Olea B; Navarro D
    Clin Microbiol Infect; 2021 Nov; 27(11):1672-1677. PubMed ID: 34174397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Outbreaks in Nursing Homes Despite Full Vaccination with BNT162b2 of a Majority of Residents.
    Lafuente-Lafuente C; Rainone A; Guérin O; Drunat O; Jeandel C; Hanon O; Belmin J;
    Gerontology; 2022; 68(12):1384-1392. PubMed ID: 35313315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals.
    Fraley E; LeMaster C; Geanes E; Banerjee D; Khanal S; Grundberg E; Selvarangan R; Bradley T
    BMC Med; 2021 Jul; 19(1):169. PubMed ID: 34304742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID-19 during a SARS-coronavirus-2 outbreak in a senior citizen home in Germany.
    Schwarzer R; Freys SD; Neuwinger N; Beikert N; Eberspächer B; Edelmann A; Zuchowski M; Slothouwer I; Stein A; Theil K; Menzel P; Hofmann J
    Immun Inflamm Dis; 2021 Dec; 9(4):1809-1814. PubMed ID: 34528766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection.
    Bardenheier BH; Gravenstein S; Blackman C; Gutman R; Sarkar IN; Feifer RA; White EM; McConeghy K; Nanda A; Bosco E; Mor V
    J Am Med Dir Assoc; 2021 Nov; 22(11):2228-2232. PubMed ID: 34534492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-SARS-CoV-2 IgG antibody after the second and third mRNA vaccinations in staff and residents in a nursing home with a previous COVID-19 outbreak in Niigata, Japan.
    Wagatsuma K; Saito R; Yoshioka S; Yamazaki S; Sato R; Iwaya M; Takahashi Y; Chon I; Naito M; Watanabe H
    J Infect Chemother; 2024 Feb; 30(2):164-168. PubMed ID: 37739181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single Dose of an mRNA Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) Vaccine Is Associated With Lower Nasopharyngeal Viral Load Among Nursing Home Residents With Asymptomatic Coronavirus Disease 2019 (COVID-19).
    McEllistrem MC; Clancy CJ; Buehrle DJ; Lucas A; Decker BK
    Clin Infect Dis; 2021 Sep; 73(6):e1365-e1367. PubMed ID: 33768222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.
    Hatfield KM; Baggs J; Wolford H; Fang M; Sattar AA; Montgomery KS; Jin S; Jernigan J; Pilishvili T
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S147-S154. PubMed ID: 35856635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.